Interactions between cardiovascular and cerebrovascular disease.

Area of Science:

• Cardiology
• Neurology
• Vascular Surgery

Background:

• Ischemic stroke often coexists with cardiovascular disease, necessitating integrated management strategies.
• Carotid artery disease is a significant risk factor for ischemic stroke.
• Optimal treatment pathways for patients with concurrent coronary and carotid artery disease remain an area of active research.

Purpose of the Study:

• To provide recommendations for the cardiovascular risk assessment and management of patients with ischemic stroke.
• To clarify the role of coronary artery disease testing in patients undergoing evaluation for carotid artery disease.
• To outline therapeutic strategies for stroke prevention in various patient populations.

Main Methods:

• This is an opinion statement based on current evidence and expert consensus.
• Review of existing guidelines and clinical trial data.
• Formulation of clinical recommendations for patient management.

Main Results:

• Comprehensive cardiovascular risk assessment is recommended for all ischemic stroke patients.
• Noninvasive coronary artery disease testing may be considered for select patients with carotid artery disease and stroke symptoms.
• Routine coronary artery disease testing before carotid endarterectomy is not advised.
• Aggressive treatment is recommended for patients with coexisting coronary and carotid artery disease.
• Preoperative coronary angiography and revascularization are not recommended for patients undergoing carotid revascularization.
• Warfarin is recommended for moderate to high stroke risk; novel oral anticoagulants are alternatives but lack established clinical practice guidelines.
• Left atrial appendage closure may be considered for stroke prophylaxis in specific atrial fibrillation patients.
• Warfarin is not indicated for heart failure patients in sinus rhythm.
• Percutaneous closure of patent foramen ovale is not superior to medical therapy for cryptogenic stroke recurrence prevention.

Conclusions:

• Integrated cardiovascular risk assessment and management are crucial for ischemic stroke patients.
• Treatment decisions regarding coronary artery disease and stroke prevention should be individualized based on patient profiles and risk factors.
• Further research is needed to establish the role of novel oral anticoagulants and specific interventional procedures in stroke prevention.